Global Sepsis Market
HealthcareServices

Sepsis Market Size and Demand Forecast 2026–2030

Uncover key drivers, emerging technologies, and competitive movements shaping the sepsis market from 2026–2035 with trusted insights from The Business Research Company

How is the Sepsis Market size predicted to change over the forecast window of 2026–2035?

The sepsis market size has shown significant expansion in recent years. It is anticipated to increase from $1.02 billion in 2025 to $1.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. The past growth in this market can be ascribed to several factors, including a high incidence of sepsis, elevated hospital care standards, the implementation of clinical protocols, the establishment of sepsis awareness programs, and modern ICU setups.

The sepsis market is projected to experience robust expansion over the coming years, with its valuation anticipated to reach $1.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This projected growth is driven by factors such as AI-assisted early detection, the broader adoption of point-of-care monitoring, seamless integration with EHR systems, the development of advanced therapeutics for sepsis, and the widespread adoption of global sepsis management guidelines. Key developments expected during this period encompass early sepsis detection tools, AI-powered risk scoring methodologies, point-of-care sepsis monitors, the integration of tele-ICU services, and the implementation of protocol-driven treatment solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp

Which Drivers Are Contributing To The Expansion Of The Sepsis Market?

The anticipated expansion of the sepsis market is significantly influenced by the increasing prevalence of infectious diseases. These illnesses stem from the invasion of the body by microorganisms such as bacteria, viruses, fungi, or parasites. Common examples include tuberculosis, flu, ringworm, and malaria, which transmit through contact, contaminated sources, or insect vectors. The rise in infectious disease incidence is attributable to population growth, globalization, environmental changes, the emergence of drug-resistant pathogens, and existing gaps in healthcare systems. Sepsis represents a serious complication of infectious diseases, arising from the body’s overwhelming reaction to an infection, which results in widespread inflammation and potential organ failure. For instance, in November 2024, the Centers for Disease Control and Prevention, a US-based government agency for public health, reported that the United States recorded 9,633 cases of tuberculosis (TB) in 2023, marking a 15.6% rise from 8,332 cases documented in 2022. Consequently, the escalating burden of infectious diseases is a primary driver for the growth of the sepsis market.

What Segment Classifications Make Up The Sepsis Market?

The sepsis market covered in this report is segmented –

1) By Type: Diagnosis, Therapeutics

2) By Pathogen: Bacterial, Viral, Fungal

3) By Application: Severe Sepsis, Septic Shock

4) By End User: Hospitals, Pathology, Reference Laboratories

Subsegments:

1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods

2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options

Which Trends Are Shaping Activity Within The Sepsis Market?

Key companies operating within the sepsis sector are directing their efforts towards creating technologically sophisticated platforms, such as those driven by artificial intelligence (AI), to improve early detection, enhance treatment accuracy, and forecast patient prognoses. This strategy ultimately aims to decrease mortality rates and boost healthcare efficiency in managing sepsis. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare firm, launched its AI software platform, OpenDX. This pioneering platform combines AI-powered diagnostics with wearable biosensors, empowering healthcare providers to identify the initial indicators of sepsis. This innovation assists in sepsis diagnosis and possesses the capability to extend to other health conditions, thereby highlighting technology’s critical function in diagnostics. Predicate’s chest sensor specifically aids healthcare personnel in detecting early signs of sepsis, a condition that is both challenging to diagnose and frequently overlooked.

Which Leading Companies Dominate The Sepsis Market Share?

Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Asahi Kasei Corporation, Becton Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, DiaSorin S.p.A., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report

How Does The Sepsis Market Perform Across Major Global Regions?

North America was the largest region in the sepsis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sepsis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21286&type=smp

Browse Through More Reports Similar to the Global Sepsis Market 2026, By The Business Research Company

Clinical Microbiology Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-microbiology-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Hemophilia Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model